We identified UBQLN1 non-sense mutations in 31% (Q176*) and 53% (G499*) of variants reads from the TCGA and non-TCGA non-redundant breast and lung cancers studies, respectively (Tables S2 and S3). This evidence concerns the gene UBQLN1 and lung cancer.